Caring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement

Caring Brands (CABR) completed an initial $4.6 million closing on September 1, 2026 under a $9 million private placement of convertible preferred shares to accredited investors.

Rhea-AI Summary

Caring Brands (CABR) completed an initial $4.6 million closing on September 1, 2026 under a $9 million private placement of convertible preferred shares to accredited investors.

The company reports that an additional $4.4 million of subscription documents have been executed and funds are pending clearance. Subject to closing conditions, it expects by September 4, 2026 to issue 4,400 Series B preferred shares and Series A and B warrants covering up to 8.8 million common shares. Proceeds from the initial closing will fund a new proprietary salesforce and domestic and international marketing campaigns, which management believes will accelerate revenue growth.

Positive

• $4.6 million initial capital raised via convertible preferred shares
• Executed subscription documents for a further $4.4 million in funding
• Proceeds earmarked to build proprietary salesforce and expand marketing
• Potential issuance of 4,400 Series B preferred shares and warrants for up to 8.8 million common shares on fund release

Negative

• Full $9 million private placement is not yet funded or assured
• Planned issuance of up to 8.8 million warrant shares implies future dilution risk for common shareholders
• Additional closing remains subject to satisfaction or waiver of closing conditions and may not occur in whole or in part

News Explained

The financing’s ownership impact remains unquantified, while its full $9 million size equals 1768.6 days of Q2 operating cash use.

The financing is partly closed, but the potential common-ownership change from the securities remains unquantified because the release does not state the preferred-stock conversion amount.

If the convertible preferred shares convert or the warrants are exercised into common shares, the added common shares would reduce existing holders’ percentage ownership absent offsets.

Compared on the last reported quarterly operating cash-use basis, the stated $9 million offering equals 1768.6 days of that use, while June 30 cash and equivalents equals 357.7 days at the same rate.

Sources and calculations

• Caring Brands private placement update (2026-09-02)
• Dilution definition (undated)
• Caring Brands second-quarter 2026 fundamentals (2026-06-30)

• Offering gross against the last reported quarterly operating outflow, in days at that rate $9,000,000 / ($463,073 / 91) = 1768.6 days
• Available liquidity against the last reported quarterly operating outflow, in days at that rate $1,820,365 / ($463,073 / 91) = 357.7 days

Market reaction after initial private placement closing: CABR +9.90%

+9.90% $1.48

15m delay

+9.90% Vs previous close

+19.3% Peak Tracked

$1.48 Last Price

$1.43 $1.50 Day Range

$15.38M Market Cap

0.0x Rel. Volume

Following this news, CABR has gained 9.90%, reflecting a notable positive market reaction. Argus tracked a peak move of +19.3% during the session. Our momentum scanner has triggered 2 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $1.48.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

A -17.08% 24-hour move followed CABR's August 06 intellectual-property update. Against that company-...

Analysis

A -17.08% 24-hour move followed CABR's August 06 intellectual-property update. Against that company-specific history, this financing update warranted attention to closing certainty and security issuance, with low short positioning and no recent insider activity as additional context.

Key Figures

Purchase agreement: $9.0 million Initial closing: $4.6 million Additional subscriptions: $4,400,000 +4 more

7 metrics

Purchase agreement $9.0 million Ongoing private placement

Initial closing $4.6 million September 1, 2026 closing

Additional subscriptions $4,400,000 Executed subscription documents awaiting funds

Series B preferred shares 4,400 shares Expected additional issuance

Series A warrants 4,400,000 shares Expected underlying common-stock warrants

Series B warrants 4,400,000 shares Expected underlying common-stock warrants

Expected closing date September 4, 2026 Subject to closing conditions

Historical Context

2 past events · Latest: Aug 06 (Positive)

Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 06	IP portfolio update	Positive	-17.1%	Five issued U.S. patents supported two product platforms; listing compliance risk was reiterated.
Jun 01	Licensing agreement	Positive	+17.1%	Expanded five-year, multi-territory rights for Photocil and Hair Enzyme Booster.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

CABR's prior news reactions were mixed, with one positive announcement followed by a gain and one positive announcement followed by a decline.

Key Terms

private placement, convertible preferred shares, accredited investors, form 8-k, +1 more

5 terms

private placement financial

"Caring Brands Inc. Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

convertible preferred shares financial

"the Company issued and sold to certain accredited investors the initial $4.6 Million in convertible preferred shares"

Convertible preferred shares are a type of stock that pays priority dividends and has a higher claim on assets than common shares, but can be exchanged later for a set number of common shares. For investors, they offer a safety-and-upside mix: steady income and protection like a senior ticket, plus the option to convert into common stock if the company grows — a decision that affects potential returns and how much existing owners’ stakes may be diluted.

accredited investors regulatory

"issued and sold to certain accredited investors the initial $4.6 Million"

Accredited investors are individuals or entities considered to have enough financial knowledge and resources to understand and handle more complex and risky investments. They are often allowed to participate in private investment opportunities that are not available to the general public, similar to how experienced players might access exclusive clubs or events. This status helps ensure that investors can manage potential risks and rewards appropriately.

form 8-k regulatory

"In the Current Report on Form 8-K, the Company said"

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

warrants financial

"Series A Warrants to purchase up to 4,400,000 shares of Common Stock"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

According To Company’s Recent 8K, The Company Initially Closed On $4.6 Million Of A $9.0 Million Round That Is In Progress On A Rolling Basis

Company Will Use Initial Closing Proceeds To Launch Company’s New Salesforce And Marketing Campaigns

Fort Pierce, FL, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) a wellness consumer-products company, today provided an update regarding the status of its $9 Million Purchase Agreement.

On September 1, 2026, the Company completed an initial closing under the Purchase Agreement (the “Initial Closing”), pursuant to which the Company issued and sold to certain accredited investors the initial $4.6 Million in convertible preferred shares.

In the Current Report on Form 8-K, the Company said: “The Company expects to complete one or more additional closings under the Purchase Agreement on a rolling basis with Investors that are party to the Purchase Agreement. As of the date of this Current Report on Form 8-K, an additional $4,400,000 of subscription documents have been executed and the Company is waiting for these funds to clear. Upon the release of such funds to the Company, it expects to issue an additional 4,400 shares of Series B Preferred Stock, Series A Warrants to purchase up to 4,400,000 shares of Common Stock and Series B Warrants to purchase up to 4,400,000 shares of Common Stock. The Company expects such release and issuance to occur on or before September 4, 2026, subject to the satisfaction or waiver of the applicable closing conditions. No assurance can be given that any such additional closing will be completed, in whole or in part, or as to the timing or amount thereof.”

Dr. Glynn Wilson, Chief Executive Officer of Caring Brands said: “We are now ready to begin funding our full domestic and international marketing campaigns and create the Company’s proprietary salesforce, moves that should enable us to substantially increase revenues at a quicker pace.”

About Caring Brands

Caring Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth. The Company intends to launch a total of five products over the next two years in addition to in-licensing additional products. Management has a successful track record of strategic acquisitions, rapid product development, IP development and product licensing. Revenues from the sales of Hair Enzyme Booster for the treatment of hair loss, and Photocil for the treatment of psoriasis and vitiligo, are currently being generated by direct sales in the US and licensees in India. Additional product opportunities include CB-101 for the treatment of eczema, NoStingz, a sunscreen that prevents jellyfish stings.

Contact:

Brian S John
Chief Investment Officer
(561) 896-7616

Forward-Looking Statements
This communication contains forward-looking statements regarding Caring Brands, Inc., including statements concerning the Company’s intellectual property strategy, product development and commercialization, licensing opportunities and potential strategic relationships, the Company’s ability to regain compliance with Nasdaq listing requirements and the outcome of the Hearings Panel proceeding, and the activities and commercialization plans of the Company’s existing licensees. Forward-looking statements may be identified by words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “explore,” “evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “project,” “seek,” “should” or “will,” and similar expressions. These statements are based on the Company’s current plans, objectives, estimates and expectations and inherently involve risks and uncertainties, many of which are beyond its control. Actual results and the timing of events could differ materially as a result of these risks and uncertainties, including the outcome of patent prosecution; challenges involving patent validity, enforceability, ownership or scope; regulatory developments; development and manufacturing risks; market acceptance; competition; access to capital; and the other risks described under Item 1A, “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed on March 31, 2026, and in its subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, available at www.sec.gov. Investors are cautioned that forward-looking statements are not guarantees of future performance. The statements in this communication speak only as of the date made, and Caring Brands undertakes no obligation to update or supplement them, except as required by law.

FAQ

What did Caring Brands (CABR) announce about its $9 million private placement?

Caring Brands announced completion of an initial $4.6 million closing under a $9 million private placement of convertible preferred shares to accredited investors, with additional closings expected on a rolling basis, subject to closing conditions.

How much capital has Caring Brands (CABR) raised so far in the private placement?

Caring Brands has completed an initial closing for $4.6 million. It also reports executed subscription documents for an additional $4.4 million, with those funds still awaiting clearance before any related securities are issued.

What securities will Caring Brands (CABR) issue in the next private placement closing?

Upon release of the additional $4.4 million, Caring Brands expects to issue 4,400 shares of Series B Preferred Stock and Series A and Series B Warrants to purchase up to 4,400,000 shares of common stock each, subject to closing conditions.

When does Caring Brands (CABR) expect the next private placement funds to be released?

The company expects the release of the additional $4.4 million in funds and related securities issuance to occur on or before September 4, 2026, subject to satisfaction or waiver of applicable closing conditions and with no assurance of completion.

How will Caring Brands (CABR) use the proceeds from the initial $4.6 million closing?

The company plans to use the $4.6 million initial proceeds to launch full domestic and international marketing campaigns and build a proprietary salesforce, which management says should help increase revenues at a quicker pace.

Does the Caring Brands (CABR) private placement involve potential dilution for shareholders?

Yes. In addition to preferred shares, the company expects to issue Series A and B Warrants covering up to 8,800,000 common shares in the next closing, which would increase the potential common share count if exercised.

Is the remaining $4.4 million of Caring Brands (CABR) private placement guaranteed to close?

No. While $4.4 million of subscription documents are executed, the company states there is no assurance any additional closing will be completed, in whole or in part, or as to its timing or amount.